title: Periprocedural anticoagulation therapy for devices and atrial fibrillation ablation.
abstract: This EP Wire surveyed clinical practice with regard to the use of antithrombotic therapy in relation to device implantation (pacemakers, ICT, resynchronization therapy) and atrial fibrillation ablation in 71 centres-members of the European Heart Rhythm Association research network. The results of this survey show variation in clinical practice, but reassuringly some consistency with guidelines and consensus recommendations on the management of periprocedure (devices, ablation) antithrombotic therapy.
authors.affiliation: University of Birmingham Centre for Cardiovascular Sciences, City Hospital Birmingham, England, UK. g.y.h.lip@bham.ac.uk
authors.forename: Gregory Y H
authors.initials: GY
authors.lastname: Lip
authors.forename: Alessandro
authors.initials: A
authors.lastname: Proclemer
authors.forename: Nikolaus
authors.initials: N
authors.lastname: Dagres
authors.forename: Maria Grazia
authors.initials: MG
authors.lastname: Bongiorni
authors.forename: Thorsten
authors.initials: T
authors.lastname: Lewalter
authors.forename: Carina
authors.initials: C
authors.lastname: Blomström-Lundqvist
mesh_terms: D000925:Anticoagulants / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000188:drug therapy / Q000453:epidemiology / Q000601:surgery; D002304:Cardiac Pacing, Artificial / Q000706:statistics & numerical data*; D058406:Cardiac Resynchronization Therapy / Q000706:statistics & numerical data; D017115:Catheter Ablation / Q000706:statistics & numerical data*; D017147:Defibrillators, Implantable / Q000706:statistics & numerical data; D019538:Health Care Surveys; D006801:Humans; D011364:Professional Practice / Q000706:statistics & numerical data; D018570:Risk Assessment / Q000379:methods; D012307:Risk Factors
chemical_list: D000925:Anticoagulants